(Q42479721)

1 November 2017

First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment (English)

1 reference

1 November 2017

1 reference

Asli Sarandol

1

1 reference

1 November 2017

Emre Sarandol

2

1 reference

1 November 2017

Hacer Ebru Acikgoz

3

1 reference

1 November 2017

Salih Saygin Eker

4

1 reference

1 November 2017

Cengiz Akkaya

5

1 reference

1 November 2017

Melehat Dirican

6

1 reference

1 November 2017

14 July 2015

1 reference

Psychiatry and Clinical Neurosciences

1 November 2017

1 reference

1 November 2017

69

1 reference

1 November 2017

11

1 reference

1 November 2017

699-707

1 reference

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

1 November 2017

1 reference

Treatment implications of the schizophrenia prodrome

21 January 2018

1 reference

Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes.

21 January 2018

1 reference

Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis

21 January 2018

1 reference

Cognitive functions in prepsychotic patients.

21 January 2018

1 reference

Neuroanatomical markers of genetic liability to psychosis and first episode psychosis: a voxelwise meta-analytical comparison

21 January 2018

1 reference

Diagnostic stability of first-episode psychosis and predictors of diagnostic shift from non-affective psychosis to bipolar disorder: a retrospective evaluation after recurrence

21 January 2018

1 reference

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons

21 January 2018

1 reference

Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis

21 January 2018

1 reference

Oxidative injury and potential use of antioxidants in schizophrenia

21 January 2018

1 reference

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

21 January 2018

1 reference

Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas

21 January 2018

1 reference

Electroconvulsive therapy improves antipsychotic and somnographic responses in adolescents with first-episode psychosis--a case-control study.

21 January 2018

1 reference

Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia

21 January 2018

1 reference

Identification of blood biomarkers for psychosis using convergent functional genomics.

21 January 2018

1 reference

Cerebrospinal fluid diagnostics in first-episode schizophrenia.

21 January 2018

1 reference

Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection

21 January 2018

1 reference

Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease.

21 January 2018

1 reference

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

21 January 2018

1 reference

Substrate kinetics of erythrocyte membrane Na,K-ATPase and lipid peroxides in schizophrenia

21 January 2018

1 reference

Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: A 12-months follow-up study

21 January 2018

1 reference

Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study.

21 January 2018

1 reference

Reduced plasma antioxidants in first-episode patients with schizophrenia.

21 January 2018

1 reference

Free radical pathology and antioxidant defense in schizophrenia: a review

21 January 2018

1 reference

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients

21 January 2018

1 reference

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

Association between symptom improvement and change of body mass index, lipid profile, and leptin, ghrelin, and cholecystokinin levels during 6-week olanzapine treatment in patients with first-episode psychosis.

21 January 2018

1 reference

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PCN.12333

1 reference

1 November 2017

1 reference